Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs
Abstract. Host immune surveillance can achieve powerful clearance of infectious pathogens. Acute human immunodeficiency virus type I (HIV-1) infection can establish viral reservoirs in humans, and persistent chronic activation by the virus exhausts the immune system and ultimately causes acquired im...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health - Lippincott Williams Wilkins
2022-10-01
|
| Series: | Infectious Diseases & Immunity |
| Online Access: | http://journals.lww.com/10.1097/ID9.0000000000000066 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850210300600516608 |
|---|---|
| author | Guo-Fen Re Bei-Bei Tang Jing Kou Chen Hong Yi-Qun Kuang |
| author_facet | Guo-Fen Re Bei-Bei Tang Jing Kou Chen Hong Yi-Qun Kuang |
| author_sort | Guo-Fen Re |
| collection | DOAJ |
| description | Abstract. Host immune surveillance can achieve powerful clearance of infectious pathogens. Acute human immunodeficiency virus type I (HIV-1) infection can establish viral reservoirs in humans, and persistent chronic activation by the virus exhausts the immune system and ultimately causes acquired immunodeficiency syndrome. Although antiretroviral therapy (ART) can reduce the viral load and viremia in patients, latent HIV-1 reservoirs are still the biggest challenge that needs to be overcome to eradicate the virus. However, the low or absent viral antigen expression and epitope mutation caused during durable ART result in host immune escape and reservoir cell inaccessibility. In addition, durable ART accompanied by inflammation and persistent activation of immune cells, especially dysfunction and/or exhaustion of T cells. With the development of immunology, genetics, and genetic engineering technology, researchers can construct chimeric antigen receptors (CARs) to modify immune cells to enhance HIV clearance. The important research goals of creating CARs to modify natural killer (NK) and T cells are an attempt to enhance the functional effects of immune cells and restore the function of the immune system. This article reviews the latent characteristics of HIV, the development of CAR molecules, and the strategies for reprogramming T cells and NK cells with CARs, and aims to clear the HIV reservoirs and related potential problems. |
| format | Article |
| id | doaj-art-7fdc39eed89b4efba0163b5f07a7336f |
| institution | OA Journals |
| issn | 2096-9511 2693-8839 |
| language | English |
| publishDate | 2022-10-01 |
| publisher | Wolters Kluwer Health - Lippincott Williams Wilkins |
| record_format | Article |
| series | Infectious Diseases & Immunity |
| spelling | doaj-art-7fdc39eed89b4efba0163b5f07a7336f2025-08-20T02:09:48ZengWolters Kluwer Health - Lippincott Williams WilkinsInfectious Diseases & Immunity2096-95112693-88392022-10-012425326210.1097/ID9.0000000000000066202210000-00008Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV ReservoirsGuo-Fen Re0Bei-Bei Tang1Jing Kou2Chen Hong3Yi-Qun Kuang41 NHC Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, Yunnan 650032, China3 Center for Translational Medicine, Huaihe Clinical College, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, China4 Institute of Infection and Immunity, Henan University, Kaifeng, Henan 475000, China.3 Center for Translational Medicine, Huaihe Clinical College, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, China1 NHC Key Laboratory of Drug Addiction Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, Yunnan 650032, ChinaAbstract. Host immune surveillance can achieve powerful clearance of infectious pathogens. Acute human immunodeficiency virus type I (HIV-1) infection can establish viral reservoirs in humans, and persistent chronic activation by the virus exhausts the immune system and ultimately causes acquired immunodeficiency syndrome. Although antiretroviral therapy (ART) can reduce the viral load and viremia in patients, latent HIV-1 reservoirs are still the biggest challenge that needs to be overcome to eradicate the virus. However, the low or absent viral antigen expression and epitope mutation caused during durable ART result in host immune escape and reservoir cell inaccessibility. In addition, durable ART accompanied by inflammation and persistent activation of immune cells, especially dysfunction and/or exhaustion of T cells. With the development of immunology, genetics, and genetic engineering technology, researchers can construct chimeric antigen receptors (CARs) to modify immune cells to enhance HIV clearance. The important research goals of creating CARs to modify natural killer (NK) and T cells are an attempt to enhance the functional effects of immune cells and restore the function of the immune system. This article reviews the latent characteristics of HIV, the development of CAR molecules, and the strategies for reprogramming T cells and NK cells with CARs, and aims to clear the HIV reservoirs and related potential problems.http://journals.lww.com/10.1097/ID9.0000000000000066 |
| spellingShingle | Guo-Fen Re Bei-Bei Tang Jing Kou Chen Hong Yi-Qun Kuang Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs Infectious Diseases & Immunity |
| title | Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs |
| title_full | Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs |
| title_fullStr | Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs |
| title_full_unstemmed | Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs |
| title_short | Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs |
| title_sort | chimeric antigen receptor modified immune cells for eradication of hiv reservoirs |
| url | http://journals.lww.com/10.1097/ID9.0000000000000066 |
| work_keys_str_mv | AT guofenre chimericantigenreceptormodifiedimmunecellsforeradicationofhivreservoirs AT beibeitang chimericantigenreceptormodifiedimmunecellsforeradicationofhivreservoirs AT jingkou chimericantigenreceptormodifiedimmunecellsforeradicationofhivreservoirs AT chenhong chimericantigenreceptormodifiedimmunecellsforeradicationofhivreservoirs AT yiqunkuang chimericantigenreceptormodifiedimmunecellsforeradicationofhivreservoirs |